The epidermis of chronic idiopathic lichen planus during topical treatment with the vitamin D3 analogue KH 1060

Clinical and Experimental Dermatology

Volumn 23, Issue 1, 1998, Pages 14-18

  Glade, C P ^a   Van Der Vleuten, C J M ^a   Van Erp, P E J ^a   De Jong, E M J J ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LEXACALCITOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; IMMUNOREGULATION; LICHEN PLANUS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; TOPICAL DRUG ADMINISTRATION;

CALCITRIOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; LICHEN PLANUS; MALE; MIDDLE AGED; MITOSIS; S PHASE; SKIN;

EID: 0031978654     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1998.00287.x     Document Type: Article

References (16)

1. Ellis FA. Histopathology of lichen planus based on analysis of one hundred biopsy specimens. J Invest Dermatol 1967; 48: 143-8.
2. André J, Laporte M, Delavault P. Lichen planus: etiopathogenesis. Acta Stomatol 1990; Bel 87; 4: 229-31.
3. Morhenn VB. Etiology of lichen planus. Am J Dermatopathol 1986; 8: 154-6.
4. Depanfilis G, Manura G, Sansoni P et al. T-cell infiltrate in lichen planus. Demonstration of activated lymphocytes using monoclonal antibodies. J Cutan Pathol 1983; 10: 52-8.
5. Gianotti B, Pimpinelli N. Topical corticosteroids. Which drug and when? Drugs 1992; 44: 65-71.
6. Conzales E, Montaz TK, Freedman S. Bilateral comparison of generalised lichen planus treated with psoralens and ultraviolet. J Am Acad Dermatol 1984; 10: 958-61.
7. Viglioglia PA, Villanueva CR, Mortorano AD, Cahuepe AM. Efficacy of acitretin in severe cutaneous lichen planus. J Am Acad Dermatol 1990; 22: 852-3.
8. Laurberg G, Geiger JM, Hjorth N et al. Treatment of lichen planus with acitretin. J Am Acad Dermatol 1991; 24: 434-7.
9. Eisen D, Ellis CN. Topical cyclosporine for oral mucosal disorders. J Am Acad Dermatol 1990; 23: 1259-64.
10. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochemical Pharmacol 1991; 42: 1569-75.
11. Veyron P, Pamphile R, Binderup L, Tourain JL. Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice. Transplant Immunol 1993; 1: 72-6.
12. Lillevang ST, Rosenkvist J, Andersen LB et al. Single and combined effects of the vitamin D analogue KH 1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the Bn rat. Clin Exp Immunol 1992; 88: 301-6.
13. 3 analogue KH 1060 in the topical therapy of psoriasis. Acta Dermatovenereol 1994; 74: 398-402.
14. Glade CP, Seegers BAMPA, Meulen EFJ et al. Multiparameter flow cytometrical characterization of epidermal cell suspensions prepared from normal and hyperproliferative skin using an optimized thermolysin-trypsin protocol. Arch Dermatol Res 1996; 288: 203-10.
15. Marks R, Black M, Jones EW. Epidermal cell kinetics in lichen planus. Br J Dermatol 1973; 88: 37-45.
16. 3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation. Acta Dermatovenereol 1995; 75: 381-5.